Fact CheckerSign in

NCT05658250Active, not recruiting

CREATE Trial, Prospective, Observational Study

Feasibility of CRE8 Polymer-free Amphilimus-eluting sTEnt in Patients With Diffuse Long Lesions (CREATE Trial): Prospective, Observational Study

Source: ClinicalTrials.gov · Last updated 25 Nov 2025

Brief summary (registry, in English)

Observation of the safety and effectiveness of Cre8 stent, Cre8 evo stent in patients with ischemic heart disease with long coronary lesions

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
12 Dec 2022
Start date
3 Aug 2021
Primary completion date
31 Dec 2027
Lead sponsor
Yonsei University
NCT number
NCT05658250

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 3 Aug 2021 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Subjects with known hypersensitivity or contraindication to the following drugs or substances: heparin, aspirin, clopidogrel, prasugrel, ticagrelor

Other

  • Remaining life expectancy is less than 1 year
  • In case the other researcher judges that it is inappropriate to participate in this study (pregnant women, the elderly, etc.)

Who the study is looking for

  • 19 years of age or older
  • Clinical evidence of coronary artery disease, including asymptomatic ischemia, stable angina, and acute coronary syndrome (unstable angina, non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction)
  • Coronary artery lesion length 30 mm or more
  • Those who voluntarily agreed in writing to participate in this clinical study

Age in the registry: 19 years to 90 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yongin Severance Hospital
Coordinator of this site? Confirm its status
YŏnginSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.